Cancer & advanced treatments
When your case requires something more specialised.
Aequum's healthcare-access service extends to complex oncology and selected advanced treatment programmes.
Oncology
Cancer Treatment
Aequum helps international patients obtain specialist review from selected Chinese oncology centres. Depending on the patient's diagnosis and circumstances, this may involve consideration of:
- Surgical oncology
- Medical oncology
- Radiotherapy
- Precision oncology
- Interventional oncology
- Cellular immunotherapy
- Multidisciplinary cancer treatment
Cellular immunotherapy
CAR-T Cell Therapy
China has developed one of the world's most active CAR-T clinical and commercial ecosystems. Specialist assessment for eligible patients seeking cellular immunotherapy, for selected cancers including certain:
CAR-T eligibility must always be determined by the treating clinical team.
- Lymphomas
- Leukaemias
- Multiple myeloma
- Solid tumours where appropriately approved or investigated
Particle radiotherapy
Proton & Carbon-Ion Therapy
Precision particle radiotherapy for selected cancers. Aequum can coordinate preliminary assessment for international patients interested in specialist Chinese proton therapy and carbon-ion / heavy-ion therapy programmes.
Carbon-ion therapy in particular is highly specialised, available at a limited number of centres globally.
Molecular medicine
Precision Oncology
Molecular and multidisciplinary approaches to cancer treatment.
Research programmes
Clinical Trials
Potential access to selected Chinese research programmes where the patient meets study eligibility requirements.